"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","description.1","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","data_processing.5","data_processing.6","platform_id","contact_name","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","dissease state:ch1","sample type:ch1","Sex:ch1","Stage:ch1"
"GSM3147994","CTRL rep1","GSM3147994","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C1","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231878","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106281","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147994/suppl/GSM3147994_C1.txt.gz","control","PEV","Female","No NODULES"
"GSM3147995","CTRL rep2","GSM3147995","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C2","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231877","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106282","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147995/suppl/GSM3147995_C2.txt.gz","control","PEV","Female","No NODULES"
"GSM3147996","CTRL rep3","GSM3147996","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C3","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231876","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106283","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147996/suppl/GSM3147996_C3.txt.gz","control","PEV","Male","No NODULES"
"GSM3147997","CTRL rep4","GSM3147997","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C4","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231875","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106284","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147997/suppl/GSM3147997_C4.txt.gz","control","PEV","Male","No NODULES"
"GSM3147998","CTRL rep5","GSM3147998","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C5","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231874","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106285","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147998/suppl/GSM3147998_C5.txt.gz","control","PEV","Male","No NODULES"
"GSM3147999","CTRL rep6","GSM3147999","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C6","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231873","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106286","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3147nnn/GSM3147999/suppl/GSM3147999_C6.txt.gz","control","PEV","Female","No NODULES"
"GSM3148000","CTRL rep7","GSM3148000","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: control","Stage: No NODULES","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","C7","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231872","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106287","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148000/suppl/GSM3148000_C7.txt.gz","control","PEV","Male","No NODULES"
"GSM3148001","EARLY STAGE rep1","GSM3148001","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E1","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231871","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106288","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148001/suppl/GSM3148001_E1.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148002","EARLY STAGE rep2","GSM3148002","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E2","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231870","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106289","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148002/suppl/GSM3148002_E2.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148003","EARLY STAGE rep3","GSM3148003","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IB","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E3","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231869","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106290","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148003/suppl/GSM3148003_E3.txt.gz","early stage NSCLC","PEV","Male","IB"
"GSM3148004","EARLY STAGE rep4","GSM3148004","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E4","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231868","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106291","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148004/suppl/GSM3148004_E4.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148005","EARLY STAGE rep5","GSM3148005","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E5","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231867","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106292","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148005/suppl/GSM3148005_E5.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148006","EARLY STAGE rep6","GSM3148006","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IB","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E6","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231866","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106293","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148006/suppl/GSM3148006_E6.txt.gz","early stage NSCLC","PEV","Female","IB"
"GSM3148007","EARLY STAGE rep7","GSM3148007","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E7","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231865","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106294","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148007/suppl/GSM3148007_E7.txt.gz","early stage NSCLC","PEV","Male","IA"
"GSM3148008","EARLY STAGE rep8","GSM3148008","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E8","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231864","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106295","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148008/suppl/GSM3148008_E8.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148009","EARLY STAGE rep9","GSM3148009","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E9","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231863","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106296","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148009/suppl/GSM3148009_E9.txt.gz","early stage NSCLC","PEV","Male","IA"
"GSM3148010","EARLY STAGE rep10","GSM3148010","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IA","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E10","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231862","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106297","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148010/suppl/GSM3148010_E10.txt.gz","early stage NSCLC","PEV","Female","IA"
"GSM3148011","EARLY STAGE rep11","GSM3148011","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: early stage NSCLC","Stage: IB","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","E11","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231861","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106298","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148011/suppl/GSM3148011_E11.txt.gz","early stage NSCLC","PEV","Male","IB"
"GSM3148012","LATE STAGE rep1","GSM3148012","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: IV","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L1","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231860","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106299","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148012/suppl/GSM3148012_L1.txt.gz","late stage NSCLC","PEV","Female","IV"
"GSM3148013","LATE STAGE rep2","GSM3148013","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: IV","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L2","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231859","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106300","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148013/suppl/GSM3148013_L2.txt.gz","late stage NSCLC","PEV","Female","IV"
"GSM3148014","LATE STAGE rep3","GSM3148014","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: IV","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L3","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231858","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106301","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148014/suppl/GSM3148014_L3.txt.gz","late stage NSCLC","PEV","Female","IV"
"GSM3148015","LATE STAGE rep4","GSM3148015","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: IV","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L4","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231857","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106302","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148015/suppl/GSM3148015_L4.txt.gz","late stage NSCLC","PEV","Female","IV"
"GSM3148016","LATE STAGE rep5","GSM3148016","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: III","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L5","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231856","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106303","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148016/suppl/GSM3148016_L5.txt.gz","late stage NSCLC","PEV","Female","III"
"GSM3148017","LATE STAGE rep6","GSM3148017","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: III","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L6","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231855","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106304","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148017/suppl/GSM3148017_L6.txt.gz","late stage NSCLC","PEV","Male","III"
"GSM3148018","LATE STAGE rep7","GSM3148018","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: II","Sex: Male","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L7","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231854","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106305","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148018/suppl/GSM3148018_L7.txt.gz","late stage NSCLC","PEV","Male","II"
"GSM3148019","LATE STAGE rep8","GSM3148019","Public on Jun 29 2018","May 21 2018","Jun 29 2018","SRA","1","Plasma-derived exosome","Homo sapiens","dissease state: late stage NSCLC","Stage: IV","Sex: Female","sample type: PEV","PEVs were isolated using the Izon qEV size exclusion column (Izon qEV, iZON science, Cambridge MA). 190uL of plasma (centrifuged for 10 minutes at 10,000xG) was added to the column membrane, followed by 310uL of PBS.  PBS was then added in 500uL increments for a total of 32 fractions. The fractions were run on a NuPAGE Bis-Tris gel to evaluate protein contamination.  Fractions 7-9 were combined as the EV fraction and fractions 12-32 were combined as the depleted fraction.  Both the EV and depleted fractions were concentrated to ~150uL using an Amicon Ultra-4 10K centrifugal filter (Millipore cat#UFC801024).","total RNA","Total RNA from all 3 fractions (whole plasma, EVs and EV-depleted) was isolated using the Qiagen miRNeasy kit (Qiagen) and eluted twice with 30uL H2O. RNA was isolated from 100 uL of plasma using the Qiagen miRNeasy Mini prep kit and eluted from the binding column in 15 uL H2O. The quality and quantity of RNA was checked with Bioanalyzer.","The small RNA sequencing library was constructed with NEBNext library construction kit following manufacture's instruction. The library with proper insert size was selected by using PippinHT from Sage Scientific. For pooling samples, NEBNext Library Quant Kit was used to quantify the library and equimolar amount of libraries from different samples was pooled for sequencing using Illumina NextSeq 500 (50 bp single-end reads were generated).","9606","L8","miRNA editing profiling from PEV","The detection and quantification analysis of modification events from sRNAseq data were based on two principal phases: 1) detection of miRNA editing sites by applying the Alon-Eisenberg pipeline (PMID:23872974) and 2) differential expression analysis of miRNA editing hotspots.","Briefly, we filtered all reads according to a Phred quality ≥20, with at most three positions with a lower quality. In addition, we removed sequences identified as 5' or 3' adaptors. Subsequently, we also removed reads whose length did not fall within the typical length range for a mature miRNA (16-27 bases).","Subsequently, all filtered reads were aligned to the human genome (hg19) employing the Bowtie software (PMID:19261174), allowing for one mismatch at most and trimming the last two bases of the read (PMID:20719920) (Bowtie parameters: -e 50 -a -m 1 -trim3 2 -best -strata). All the reads mapped to the known pre-miRNA sequences were considered for downstream analysis.","Finally, all miRNA MEs with the mismatch base quality score ≥30 and a Bonferroni-adjusted P-value <0.05, were taken into account for downstream analysis. The expression of each filtered miRNA MEs was calculated in RPMs. Among miRNA MEs, we have selected those which we consider to be high confidence miRNA editing sites, namely, having geometric mean of ED miRNA expression >1 RPM and geometric mean of editing level ≥5, in at least one condition (normal or tumor).","Finally, we identified as miRNA editing hotspots all high confidence miRNA editing sites present in ≥50% of samples, in at least one condition (tumor or normal).","Genome_build: hg19","Supplementary_files_format_and_content: Txt files contains the abundance measurements for all miRNAs in each sample.","GPL18573","Serge,Patrick,Nana-Sinkam","Department of Internal Medicine Division of Pulmonary Disease and Critical Care Medicine","Virginia Commonwealth University","1200 East Broad Street","Richmond","Virgina","23298","USA","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09231853","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4106306","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3148nnn/GSM3148019/suppl/GSM3148019_L8.txt.gz","late stage NSCLC","PEV","Female","IV"
